Research
We write fundamental equity research on ASX-listed companies, in which we explain the science and the financial case. Every report is free to read.
Coverage areas
Therapeutics
Diagnostics
Medical technology
Digital health
In-depth coverage that develops over time – not just a single report.
Our analytical framework
Bridge Life Sciences covers ASX-listed life science companies across therapeutics, diagnostics, medical technology and digital health, from preclinical development through to commercialisation.
Each report covers the company's financial position and funding requirements, its evidence base and regulatory pathway, and its commercial opportunity. We also provide a detailed explanation of our valuation methodology, including with key assumptions, catalysts and risks.
General information only. See Legal and Disclaimer.